Glooko Secures $100 Million Series F Financing and Appoints Mike Alvarez as Chief Executive Officer
Expert health tech leader brings extensive experience in connected care, life sciences and chronic condition management to drive global growth PALO...
Glooko Announces Presidents of Life Sciences and Connected Care
David Pass and Adam Hameed bring decades of business development, strategy and industry experience to Glooko’s leadership team Palo Alto, CA,...
Glooko Appoints Enrique Conterno, former Eli Lilly & Company Senior Executive, to Board of Directors
Glooko announced the appointment of Enrique Conterno to its Board of Directors.
Glooko Unveils Redesigned Mobile App
Glooko announced the redesign of its award-winning mobile app for its connected care platform, which will provide a more streamlined diabetes management...
Glooko Announces Partnership with Insulin Dosing Algorithm Company Hedia
Glooko announced a partnership with insulin dosing algorithm company Hedia to provide people with diabetes personalized care and bolus insulin dosing advice.
Glooko Announces Global Collaboration with Sanofi for SoloStar® Pen Connectivity with New Device SoloSmart®
Glooko Inc. announced that they have entered into a partnering agreement with Sanofi to increase their support of people living with diabetes and healthcare...
Glooko Granted ISO 27001 Certification
Glooko received ISO 27001 certification for its data management and remote patient monitoring platforms for people with diabetes and related chronic conditions.
Glooko Earns HITRUST and SOC 2 Type II Certifications
Glooko Inc., announced achieving SOC 2 Type II certification and renewal of HITRUST certification for Glooko®, its industry leading connected care platform...
Glooko Wins Distinguished dotCOMM Award
Glooko was recognized with a distinguished gold dotCOMM Award for its earned media placements and thought leadership on remote patient monitoring.
Glooko Launches Academy™ in Ireland
Glooko announced, in partnership with the Diabetes Technology Network (DTN)/ Association of British Clinical Diabetologists (ABCD), the expansion into...
Glooko Appoints Alfonso “Chito” Zulueta, former Eli Lilly & Company Senior Executive, to Board of Directors
Glooko, Inc. announced the appointment of Alfonso “Chito” Zulueta, a former Eli Lilly & Company senior executive, to its Board of Directors.
Glooko Acquires DIABNEXT® to Expand Diabetes Offerings in France
Paris-based health platform provides diabetes remote monitoring and enhances physician-patient collaboration
Glooko Collaborates with Johns Hopkins Medicine HealthCare Solutions on Clinically Proven Digital Health Technology for Chronic Conditions
Combined Offering Provides all the Components of an End-to-End Platform
Glooko Acquires Germany-Based xbird, a Medical AI Company
Acquisition expands Glooko’s digital health capabilities with machine learning
Glooko Announces Collaboration with Novo Nordisk for European Connected Pen Launches
Research Finds Connected Pens Significantly Reduce Missed Doses and Improves Time in Recommended Glucose Range
Glooko Announces New Chief Technology Officer
Glooko Inc., the leading provider of remote patient monitoring and data management platforms in diabetes and related chronic conditions, today announced...
Glooko to Present Patient Outcomes Showing Impact of Remote Patient Monitoring and Coaching on Glycemic Control in Type 2 Diabetes
A study of the use of remote patient monitoring (RPM) with diabetes patients demonstrated improved and sustained glycemic control at 3-, 6- and 12-month...
Glooko Announces Digital Health Collaboration with Eli Lilly’s Connected Insulin Pen Solutions in Global Markets
Glooko Inc., a leading provider of remote patient monitoring and data management solutions for diabetes and other chronic conditions, today announced a...
Glooko Raises $30 Million Financing Round
Glooko Inc., a leading provider of remote patient monitoring and chronic care management solutions including diabetes and obesity has raised a $30 million...
Glooko Announces New Medical Education Programme In Collaboration with the Diabetes Technology Network (DTN) / Association of British Clinical Diabetologists (ABCD)
Glooko AB (“Glooko” or “The Company”) today announced, in partnership with the Diabetes Technology Network (DTN)/ Association of British Clinical...
Glooko announces the addition of Tracy Bahl and Mike Doherty as Independent Members of the Board
As Glooko continues its journey to transform digital health by connecting people with diabetes and their health care professionals, enabling telehealth,...
Glooko provides Free Remote Care solution and collaborates with Sanofi to share with medical clinics and people with diabetes
Together, with Sanofi’s nearly 100-year heritage in diabetes and Glooko’s leadership in remotely connecting people living with diabetes and health...
Glooko Names Kyle Brown as Chief Technology Officer
As part of its continued focus on delivering data enabled solutions to improve the lives of people with diabetes, Glooko, the leader in diabetes digital...
Glooko Enables Remote Patient Care at No Charge to Medical Clinics and People with Diabetes to Minimize Risk During Pandemic
Glooko is taking action to serve the global diabetes community by providing a no-charge remote-care solution that provides live patient-to-clinician connectivity.
Glooko Names Zach Henderson as Chief Commercial Officer and Komathi Stem as Chief Operating Officer
As part of its continued global expansion, Glooko, the leader in diabetes digital health and data management solutions, today announced the appointment...
Glooko Earns Privacy Shield Certification for Policies to Safeguard Diabetes Patient Data
Glooko®, the global leader in diabetes data management, today announced it has received Privacy Shield certification from the U.S. Department of Commerce....
Glooko Receives ISO 13485 Certification
Glooko®, the global leader in diabetes data management, announced today that its Mountain View, California and Gothenburg, Sweden sites have received...
Glooko’s diasend Diabetes Data Platform to Unveil Greater Connectivity and System Enhancements at EASD Meeting in Barcelona
Glooko®, the leader in diabetes data management solutions, continues to strengthen its global position with the introduction of several new features and...
Glooko Appoints Stephen Lien as New Chief Financial Officer
Glooko®, the global leader in diabetes data management solutions, today announced the appointment of Stephen Lien as Chief Financial Officer. Lien comes...
Companion Medical and Glooko Announce Partnership Agreement to Integrate Insulin Data for Multiple Daily Injections
Companion Medical, a leader in the development of advanced insulin delivery technology to improve diabetes care, and Glooko, a leader in diabetes data...
Glooko Names Dr. Mark Clements as New Chief Medical Officer
Glooko, the leader in diabetes data management solutions, today announced the appointment of Mark Clements, MD, PhD, CPI, FAAP, as Chief Medical Officer....
Glooko Mobile App Now Free For All People with Diabetes!
Glooko, the leader in diabetes data management, announced today its mobile app (available for Android and iOS) is now free* for any person with diabetes.
Glooko announces on-the-go insulin pen data uploads via diasend®, increased CGM compatibility – and the all-new Annual Diabetes Report
Glooko, the leader in diabetes data management, is gearing up for the ATTD trade show (Advanced Technologies & Treatment for Diabetes) with several...
New customers and partnerships contribute to Glooko’s 2018 success and set stage for accelerated growth
Glooko, the leader in diabetes data management, had a successful 2018 fueled by strong growth in health system customers, international expansion, and...
Novo Nordisk plans first global launch of connected insulin pens and announces key digital health partnerships
Novo Nordisk today announced plans to make the durable, connected insulin pens NovoPen® 6 and NovoPen Echo® Plus commercially available across key markets...
Insulet Extends Partnership with Glooko in Europe to Optimise Diabetes Data Management
Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® Insulin Management...
Glooko Releases New Version of Mobile App, Presents Usability Outcomes from Mobile Insulin Dosing System (MIDS) Study
Glooko, the leader in diabetes data management, today announced participation in the 78th Annual American Diabetes Association (ADA) meeting taking place...
DreaMed Diabetes Granted FDA Authorization to Market Advisor Pro, Offering Personalized Optimization of Insulin Pump Therapy
DreaMed Diabetes, developer of personalized diabetes management solutions, announced today that the U.S Food and Drug Administration (FDA) has granted...
Glooko Introduces New Web Analytics Platform That Includes the Most Powerful Capabilities from Diasend
Glooko, the leader in diabetes data management, today announced the delivery of a new version of the Glooko Web Application (Population Tracker) that includes...
Senseonics & Glooko Announce Partnership on Integrated Diabetes Management
(NYSE-American: SENS), a medical technology company focused on the development and commercialization of transformative glucose monitoring products, today...
Glooko Study Highlights Insights Into How Diabetes Healthcare Professionals Use Continuous Glucose Monitoring (CGM) Data
Glooko, the leader in diabetes data management, today announced the results of its recent study which examined diabetes healthcare professionals’ use...
Valeritas Teams with Glooko as its Preferred Data Management Partner for V-Go® SIM™
Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company which offers patients with type 2 diabetes V-Go® Wearable Insulin Delivery device,...
Healthcare Technology Veteran, Russ Johannesson joins Glooko as CEO
Glooko, the leader in diabetes data management, today announced the appointment of Russ Johannesson as its new CEO. Outgoing CEO, Rick Altinger, will...
Glooko Improves Medical Group Patient Outcomes with Remote Diabetes Care Program
Glooko, the leader in diabetes data management, today announced the results of its pilot program with Sharp Rees-Stealy Medical Group that aimed to optimize...
FDA Clears Glooko’s Long-Acting Insulin Titration System
Glooko, the leader in diabetes data management, today announced its Mobile Insulin Dosing System (MIDS) has been cleared by the Food and Drug Administration...
Annual Glooko Study Identifies Global Diabetes Insights
Glooko, the leader in diabetes data management, today released its annual, comprehensive diabetes report based on analysis of over 8.5 billion de-identified...
Strong Growth in 2017 Among Health Systems and Payers Propels Glooko into 2018
Glooko, the leader in diabetes data management, today announced that recent growth in its Health System and Payer customer base is driving strong momentum...
Feasibility Study Shows Glooko’s Mobile Health App Improves Glycemic Control in People with Type 2 Diabetes
Glooko, the leader in diabetes data management, announced the results of a feasibility study that examined the impact of Glooko’s product, the Mobile...
Novo Nordisk and Glooko advance their digital health collaboration with launch of unique integrated app for improved diabetes management
Novo Nordisk and Glooko have announced that the new Cornerstones4Care Powered by Glooko app (C4C app) is now available to help people more effectively...
Diabetes Data Platform Leader Glooko Raises $35 Million in Series C
Glooko, the leader in diabetes data management, today announced $35 million in new funding to accelerate growth, expand international presence, and deepen...
Retrospective Studies Show that Glooko’s Mobile Health App Helps to Improve Outcomes for People with Diabetes
Glooko, the leader in diabetes data management today announced the results of two retrospective studies that examine the clinical impact of use of its...
Glooko and Dexcom Expand Relationship with Global Cloud Sharing Data Agreement
Glooko, the leader in diabetes data management, today announced an expanded agreement with Dexcom, the leader in Continuous Glucose Monitoring (CGM) for...
Fit4D and Glooko Join Forces To Provide End-to-End Solution for Diabetes Management
Fit4D, a diabetes patient engagement solution, announced a partnership today with Glooko, a global diabetes data management company, to deliver highly...
Industry Leaders Ascensia Diabetes Care and Glooko Announce Diabetes Technology Partnership to Deliver Integrated Diabetes Data Solutions
Ascensia Diabetes Care and Glooko, Inc today announced a global technology partnership designed to bring together their state-of-the-art diabetes management...
Novo Nordisk and Glooko partner to develop digital health solutions for people with diabetes
Novo Nordisk and Glooko today announced that the two companies will work together to deliver jointly-developed and branded digital health solutions for...
Atrius Health, a Pioneer Accountable Care Organization in Boston, Discusses How They Use Glooko to Remotely Monitor People with Diabetes
Atrius Health has always been an innovator when it comes to providing services to their patients.
AMC Health and Glooko Partner to Deliver Diabetes Population Management Services and Improve Diabetes Outcomes
AMC Health, the leading provider of proven remote patient monitoring and engagement solutions that are exclusively endorsed by the American Hospital Association,...
Glooko Announces Compatibility With Medtronic MiniMed Insulin Pumps and Sensors at the 2016 American Diabetes Association Conference
Glooko Inc., the leading unified platform for diabetes management, today announced compatibility with Medtronic MiniMed ® insulin pumps and sensors.
Glooko announces new ‘Glooko Advise’ decision support product line at the 2016 American Diabetes Association Conference
Glooko Inc., the leading unified platform for diabetes management, today announced its new ‘Glooko Advise’ product line, including ‘Glooko Personal...
Glooko and DreaMed Diabetes Partner to Deliver Unprecedented Type 1 Diabetes Decision Support
Glooko, Inc., provider of the leading unified platform for diabetes management, and DreaMed Diabetes, developer of innovative and patient-centric decision...
Pilot shows smartphone app and population management-facilitated Type-2 diabetes management can significantly improve blood glucose control
Glooko, the leading unified platform for diabetes management, today announced that Glooko was featured in a poster presentation on the effectiveness...
Glooko Announces Integration with the Roche Accu-Chek® Aviva Connect Blood Glucose Meters
Glooko Inc., the leading unified platform for diabetes management, today announced general availability of its integration with Roche ’s Accu-Chek Aviva...
Diabetes Thought Leaders Join the Glooko Medical Advisory Board
Glooko Inc., the leading unified platform for diabetes management, today announced the formation of its first Medical Advisory Board who will provide...
Medtronic expands access to diabetes device data through agreement with Glooko
Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced an agreement with Glooko, the trusted leader in diabetes data unification...
Glooko to Highlight Integration of Insulin Pump and Continuous Glucose Monitor (CGM) Data into Its Diabetes Management Platform at ADA 2015 Conference
Glooko Inc. today announced it will demonstrate its integration with Insulin Pumps and Continuous Glucose Monitors (CGMs) at the American Diabetes Association’s...
Glooko partners with Dexcom® and Insulet® to add leading insulin pump and CGM devices to its platform
Glooko Inc. today announced partnerships with Dexcom, Inc., developer and marketer of a continuous glucose monitoring (CGM) system, and with Insulet Corporation,...
Glooko Appoints Serdar Akin as Vice President of Product Development and Michelle de Haaff as Vice President of Marketing and Customer Success
Glooko Inc., the leading unified platform for diabetes management, today announced the addition of two new executives to its management team.
Glooko, the Leading Remote Patient Monitoring Platform for Diabetes, Raises $16.5 Million in Series B Funding From Canaan Partners, Medtronic, Social + Capital and Samsung Glooko
Glooko Inc. today announced that it has raised $16.5 Million in Series B financing. The funds will be used to expand the company’s FDA-cleared, HIPAA-compliant...
Glooko Announces Integration of Wearable Activity & Biometric Monitors into Diabetes Management Platform
Glooko Inc., announced today the integration of activity, weight and blood pressure data from leading wearable activity and biometric trackers into its...
Glooko Launches ‘MeterSync Blue’ to Bluetooth-Enable Tens of Millions of Blood Glucose Meters Worldwide
Glooko Inc., announced today the launch of Glooko MeterSync Blue, strengthening its position as the industry leader in delivering a mobile, software as...
Joslin Institute of Technology Translation (JITT) and Glooko, Introduce Hypoglycemia Awareness Product Designed to Improve Hypoglycemia Self-Management for People with Diabetes
Joslin Institute for Technology Translation (JITT) at Joslin Diabetes Center, the world’s preeminent institution in diabetes research and clinical care,...
Joslin Diabetes Center Teams with Glooko on Next Generation Diabetes Management Solution
Joslin Diabetes Center, the world’s preeminent institution in diabetes research and clinical care, and Glooko Inc. have signed an agreement to jointly...
Glooko Raises $7 Million to Enhance Diabetes Management System
Glooko Inc., makers of a FDA-cleared mobile diabetes management system , announced today it has raised $7 million in a Series A-1 round from several new...
Glooko Launches Diabetes Management System for Android
Glooko, Inc., makers of an innovative mobile solution for diabetes management, today announced it has launched an Android – compatible version of...
Glooko Receives FDA 510(k) Clearance for new Diabetes Management System, Hires Diabetes Industry Executives Holly McGarraugh as VP of Business Development and Rita Sharma as VP of Marketing
Glooko, Inc., makers of an innovative mobile solution for diabetes management , has received FDA 510(k) clearance for its next-gen Glooko System including...
Glooko Hires Former Intuit Health Executive Rick Altinger as CEO and Epocrates Executive Dean Lucas as VP of Product Development, Receives FDA 510(k) Clearance
Glooko, Inc., makers of an innovative mobile logbook solution for people with diabetes, today announces the hiring of Rick Altinger as CEO and Dean Lucas...
Backed by Former Facebook VP Chamath Palihapitiya, Glooko Steps Up Presence in Canada
Glooko, Inc., makers of an innovative mobile logbook solution for people with diabetes , today formally introduces its Glooko ™ Logbook app and Glooko...
Glooko Launches Version 1.5 of its Blood Sugar Logbook App
Glooko, Inc. , makers of an innovative mobile solution for people to log blood sugar readings, today announces Glooko ™ Logbook 1.5 for iOS devices ,...
Glooko Officially Launches in EU
Glooko, Inc ., makers of an innovative mobile logbook solution for people with diabetes , today officially launches its Glooko™ Logbook Charts in the...
Glooko Launches the Glooko IR Adapter for ACCU-CHEK
Glooko, Inc., makers of an innovative diabetes logbook solution, and Roche Diabetes Care, makers of ACCU-CHEK blood glucose monitoring systems, insulin...
The Social+Capital Partnership Invests in Mobile Diabetes Company Glooko
Glooko, provider of a unique hardware device and app solution for people with diabetes, today announced a $3.5 Series A financing round, led by The Social+Capital...
